Foresite Capital Management III

Latest statistics and disclosures from Foresite Capital Management III's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ASND, NTRA, VRNA, CBAY, and represent 100.00% of Foresite Capital Management III's stock portfolio.
  • Added to shares of these 1 stocks: NTRA.
  • Foresite Capital Management III was a net buyer of stock by $2.8M.
  • Foresite Capital Management III has $33M in assets under management (AUM), dropping by -16.92%.
  • Central Index Key (CIK): 0001645157

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management III

Companies in the Foresite Capital Management III portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/S Sponsored Ads (ASND) 47.8 $16M 134k 117.36
Natera (NTRA) 19.7 $6.5M +74% 159k 40.68
Verona Pharma Sponsored Ads (VRNA) 16.9 $5.5M 1.1M 4.99
Cymabay Therapeutics (CBAY) 15.6 $5.1M 1.6M 3.11

Past Filings by Foresite Capital Management III

SEC 13F filings are viewable for Foresite Capital Management III going back to 2015

View all past filings